AMPI Sweet Type, Formula 521, Extra Grade, spray process recall — FDA F-1773-2018
Whey powder may have the potential to be contaminated with Salmonella.
Complete FDA and NHTSA recall records dated in 2018, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Whey powder may have the potential to be contaminated with Salmonella.
This recall has been identified due to the detection of cyclamates (artificial sweetener). Use of or consumption of cyclamates may include potential health hazard. Cyclamates and its salts…
This recall has been identified due to the detection of cyclamates (artificial sweetener). Use of or consumption of cyclamates may include potential health hazard. Cyclamates and its salts…
an ingredient in this product was manufactured during the time-frame and on the same piece of equipment that was associated with a salmonella outbreak.
It was discovered that a bulk salad kit was produced using the wrong components. Instead of cashews, peanuts were packed for the kit
Product labeling does not list milk in the contains statement; however milk is listed as in ingredient.
This recall has been identified due to the detection of cyclamates (artificial sweetener). Use of or consumption of cyclamates may include potential health hazard. Cyclamates and its salts…
Potential to contain metal fragments
Product is decomposed.
This recall has been identified due to the detection of cyclamates (artificial sweetener). Use of or consumption of cyclamates may include potential health hazard. Cyclamates and its salts…
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Presence of Particulate Matter: organic and inorganic compounds detected in vials of product.
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the…
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.